Zimmer Biomet Holdings Total Liabilities decreased by 3.3% to $10.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.7%, from $9.78B to $10.04B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows a downward trend with a -3.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.64B | $11.29B | $10.79B | $9.60B | $9.33B | $9.08B | $9.04B | $9.09B | $8.92B | $8.70B | $9.01B | $8.85B | $8.77B | $9.34B | $8.89B | $9.78B | $10.33B | $10.72B | $10.39B | $10.04B |
| QoQ Change | — | -3.0% | -4.5% | -11.1% | -2.8% | -2.6% | -0.5% | +0.5% | -1.9% | -2.4% | +3.6% | -1.8% | -0.9% | +6.5% | -4.8% | +10.0% | +5.6% | +3.8% | -3.1% | -3.3% |
| YoY Change | — | — | — | — | -19.9% | -19.6% | -16.2% | -5.3% | -4.4% | -4.2% | -0.3% | -2.6% | -1.6% | +7.3% | -1.3% | +10.6% | +17.8% | +14.8% | +16.8% | +2.7% |